AU6270600A - Oligosaccharide metabolites of glycosaminoglycans and their use in the diagnosisand treatment of complications of diabetes - Google Patents

Oligosaccharide metabolites of glycosaminoglycans and their use in the diagnosisand treatment of complications of diabetes

Info

Publication number
AU6270600A
AU6270600A AU62706/00A AU6270600A AU6270600A AU 6270600 A AU6270600 A AU 6270600A AU 62706/00 A AU62706/00 A AU 62706/00A AU 6270600 A AU6270600 A AU 6270600A AU 6270600 A AU6270600 A AU 6270600A
Authority
AU
Australia
Prior art keywords
diagnosisand
glycosaminoglycans
oligosaccharide
metabolites
complications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62706/00A
Other languages
English (en)
Inventor
Bernard Bizzini
Maurizio Magara
Giovanni Scapagnini
Flavio Veneroni
Ivo Volpato
Lorenzo Volpato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIDIFARM Srl
Original Assignee
BIDIFARM Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIDIFARM Srl filed Critical BIDIFARM Srl
Publication of AU6270600A publication Critical patent/AU6270600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU62706/00A 1999-07-08 2000-07-07 Oligosaccharide metabolites of glycosaminoglycans and their use in the diagnosisand treatment of complications of diabetes Abandoned AU6270600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI99A1503 1999-07-08
IT1999MI001503A ITMI991503A1 (it) 1999-07-08 1999-07-08 Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
PCT/EP2000/006474 WO2001004632A1 (en) 1999-07-08 2000-07-07 Oligosaccharide metabolites of glycosaminoglycans and their use in the diagnosis and treatment of complications of diabetes

Publications (1)

Publication Number Publication Date
AU6270600A true AU6270600A (en) 2001-01-30

Family

ID=11383300

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62706/00A Abandoned AU6270600A (en) 1999-07-08 2000-07-07 Oligosaccharide metabolites of glycosaminoglycans and their use in the diagnosisand treatment of complications of diabetes

Country Status (4)

Country Link
EP (1) EP1198709A1 (it)
AU (1) AU6270600A (it)
IT (1) ITMI991503A1 (it)
WO (1) WO2001004632A1 (it)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274351B (it) * 1994-10-06 1997-07-17 Alfa Wassermann Spa Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
DE69825653T2 (de) * 1997-04-04 2005-08-25 Seikagaku Corp. Quantitatives Bestimmungsverfahren für Heparansulfat und Diagnoseverfahren mit dessen Verwendung
DE19747195A1 (de) * 1997-10-24 1999-04-29 Knoll Ag Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
IT1299969B1 (it) * 1998-04-15 2000-04-04 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.

Also Published As

Publication number Publication date
ITMI991503A1 (it) 2001-01-08
WO2001004632A1 (en) 2001-01-18
EP1198709A1 (en) 2002-04-24
ITMI991503A0 (it) 1999-07-08

Similar Documents

Publication Publication Date Title
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU5760900A (en) Multiple agent diabetes therapy
AUPQ246799A0 (en) Surgical screw and guidewire
AU2001269478A1 (en) Hyaluronic acid oligosaccharide fractions and drugs containing the same
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU3862600A (en) Multifonctional laminate structure and process
AU5634300A (en) Composition and films thereof
AU5840200A (en) Treatment of diabetes and related pathologies
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
AU715620C (en) Therapeutic methods and uses
AU1164601A (en) Therapeutic use and formulation
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
AU5240700A (en) Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
AU1403501A (en) Novel composition and use
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
AU5056099A (en) Compounds for use in the treatment of inflammation
AU3844299A (en) Improvements in medical guidewires
AU5262200A (en) Arrangement in ventilatory treatment of the lungs
AU1321101A (en) Cholesterol lowering and blood lipids lowering composition
AU1476901A (en) Methods for regulating blood glucose and appetite suppression in type 2 diabetics
AU5842300A (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AU5134600A (en) Full-length molecules expressed in human tissues
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU7410900A (en) Alginate preparation and use of the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase